<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00284999</url>
  </required_header>
  <id_info>
    <org_study_id>PRN 05-034</org_study_id>
    <nct_id>NCT00284999</nct_id>
  </id_info>
  <brief_title>Soothe Versus Refresh</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharmaceutical Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pharmaceutical Research Network</source>
  <brief_summary>
    <textblock>
      To determine the ocular efficacy and safety of Soothe and Refresh Tears.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <completion_date>August 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>33</enrollment>
  <condition>Dry Eye Syndromes</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Soothe</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Refresh Tears</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults with a diagnosis of dry eyes

          -  Schirmer's with anesthesia grade between 1-7 mm inclusive after five (5) minutes in at
             least one eye

          -  a corneal staining grade of greater than or equal to 2 (scale 0-4) in the same
             qualifying eye as the Schirmerâ€™s test

        Exclusion Criteria:

          -  contact lens use during the active treatment periods of the trial

          -  history of Sjogren's Syndrome

          -  temporary punctal occlusion that is still effective

          -  the current or anticipated use during the study of punctual plugs

          -  current treatment with Restasis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William C. Stewart, MD</last_name>
    <role>Study Director</role>
    <affiliation>Pharmaceutical Research Network, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Penny Asbell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Chow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan Cornea Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douglas G. Day, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Coastal Research Associates, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coastal Research Associates, LLC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Cornea Associates</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029-6574</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2006</study_first_submitted>
  <study_first_submitted_qc>January 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2006</study_first_posted>
  <last_update_submitted>August 21, 2006</last_update_submitted>
  <last_update_submitted_qc>August 21, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

